Public health’s social contract: An obstacle in the advancement of effective HIV technologies

References

• Adams, L. M., & Balderson, B. H. (2016). HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: A short report. AIDS Care, 28(9), 1154–1158. doi: 10.1080/09540121.2016.1153595
   PubMed Web of Science ®Google Scholar
• Ainsworth, M., & Teokul, W. (2000). Breaking the silence: Setting realistic priorities for AIDS control in less-developed countries. The Lancet, 356(9223), 55–60. doi: 10.1016/S0140-6736(00)02440-5
   PubMed Web of Science ®Google Scholar
• Attaran, A. (2007). Adherence to HAART: Africans take medicines more faithfully than North Americans. PLoS Medicine, 4(2), e83. doi: 10.1371/journal.pmed.0040083
   PubMed Web of Science ®Google Scholar
• Auvert, B., Taljaard, D., Lagarde, E., Sobngwi-Tambekou, J., Sitta, R., Puren, A., & Deeks, S. (2005). Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial. PLoS Medicine, 2(11), e298. doi: 10.1371/journal.pmed.0020298
   PubMed Web of Science ®Google Scholar
• Avert. (2017). Treatment as prevention (TasP) for HIV. Avert. Retrieved from https://www.avert.org/professionals/hiv-programming/prevention/treatment-as-prevention
   Google Scholar
• Baeten, J. M., Palanee-Phillips, T., Brown, E. R., Schwartz, K., Soto-Torres, L. E., Govender, V., … Hillier, S. (2016). Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. New England Journal of Medicine, 375(22), 2121–2132. doi: 10.1056/NEJMoa1506110
   PubMed Web of Science ®Google Scholar
• Bailey, R. C., Moses, S., Parker, C. B., Agot, K., Maclean, I., Krieger, J. N., … Ndinya-Achola, J. O. (2007). Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. The Lancet, 369(9562), 643–656. doi: 10.1016/S0140-6736(07)60312-2
   PubMed Web of Science ®Google Scholar
• Barreiro, P. (2018). Hot news: Sexually transmitted infections on the rise in PrEP users. AIDS Review, 20(1), 70–71.
   Web of Science ®Google Scholar
• Baum, M. M., Butkyavichene, I., Gilman, J., Kennedy, S., Kopin, E., Malone, A. M., … Moss, J. A. (2012). An intravaginal ring for the simultaneous delivery of multiple drugs. Journal of Pharmaceutical Sciences, 101(8), 2833–2843. doi: 10.1002/jps.23208
   PubMed Web of Science ®Google Scholar
• Bell, K. (2015). HIV prevention: Making male circumcision the ‘right’ tool for the job. Global Public Health, 10(5-6), 552–572. doi: 10.1080/17441692.2014.903428
   PubMed Web of Science ®Google Scholar
• Blanc, A. K., Tsui, A. O., Croft, T. N., & Trevitt, J. L. (2009). Patterns and trends in adolescents’ contraceptive use and discontinuation in developing countries and comparisons with adult women. International Perspectives on Sexual and Reproductive Health, 35(2), 63–71. doi:10.1363/ipsrh.35.063.09 doi: 10.1363/3506309
   PubMed Web of Science ®Google Scholar
• Boyle, G. J., & Hill, G. (2011). Sub-Saharan African randomised clinical trials into male circumcision and HIV transmission: Methodological, ethical and legal concerns. Journal of Law and Medicine, 19(2), 316–334.
   PubMedGoogle Scholar
• Briggs, C. L., with Mantini-Briggs, C. (2003). Stories in the time of cholera: Racial profiling during a medical nightmare. Berkeley: University of California Press.
   Google Scholar
• Buchbinder, S. P. (2018). Maximizing the benefits of HIV preexposure prophylaxis. Topics in Antiviral Medicine, 25(4), 138–142.
   PubMedGoogle Scholar
• Bulled, N. (2013). New lives for old: Modernity, biomedicine, traditional culture and HIV prevention in Lesotho. Global Discourse, 3, 284–299. doi: 10.1080/23269995.2013.804700
   Google Scholar
• Bulled, N. (2015). Hesitance towards voluntary medical male circumcision in Lesotho: Reconfiguring global health governance. Global Public Health, 10, 757–772. doi: 10.1080/17441692.2014.962559
   PubMed Web of Science ®Google Scholar
• Cairns, G. P., Race, K., & Goicochea, P. (2016). PrEP: Controversy, agency and ownership. Journal of the International AIDS Society, 19(7S6), 21120. doi: 10.7448/IAS.19.7.21120
   PubMedGoogle Scholar
• Calabrese, S. K., Earnshaw, V. A., Underhill, K., Hansen, N. B., & Dovidio, J. F. (2014). The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access. AIDS and Behavior, 18(2), 226–240. doi: 10.1007/s10461-013-0675-x
   PubMed Web of Science ®Google Scholar
• Calabrese, S. K., Earnshaw, V. A., Underhill, K., Krakower, D. S., Magnus, M., Hansen, N. B., … Dovidio, J. F. (2018). Prevention paradox: Medical students are less inclined to prescribe HIV pre-exposure prophylaxis for patients in highest need. Journal of the International AIDS Society, 21(6), e25147. doi: 10.1002/jia2.25147
   PubMed Web of Science ®Google Scholar
• Cohen, J. (2018). A daily pill can prevent HIV infections. Why don't more people use it? Science. Retrieved from http://www.sciencemag.org/news/2018/03/daily-pill-can-prevent-hiv-infections-why-don-t-more-people-use-it
   Google Scholar
• Cohen, M. S., Chen, Y., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Fleming, T. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(5), 493–505. doi: 10.1056/NEJMoa1105243
   Google Scholar
• Committee on International Relations. (2001). United States Agency for International Development: The United States’ war on AIDS, House of Representatives, 107th Congress, 1st session Sess.
   Google Scholar
• Costello, D. (2005, December 19). AIDS pill as party drug? The Los Angeles Times. Retrieved from http://articles.latimes.com/2005/dec/19/health/he-hiv19
   Google Scholar
• de Camargo, K. R., de Oliveir Mendonça, A. L., Perrey, C., & Giami, A. (2013). Male circumcision and HIV: A controversy study on facts and values. Global Public Health, 8(7), 769–783. doi: 10.1080/17441692.2013.817599
   PubMed Web of Science ®Google Scholar
• Evans, D., Menezes, C., Mahomed, K., Macdonald, P., Untiedt, S., Levin, L., … Maskew, M. (2013). Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa. AIDS Research and Human Retroviruses, 29(6), 892–900. doi: 10.1089/aid.2012.0215
   PubMed Web of Science ®Google Scholar
• Farmer, P. (2004). Pathologies of power: Health, human rights, and the new war on the poor. Berkeley: University of California Press.
   Google Scholar
• Garenne, M. (2010). Mass campaigns of male circumcision for HIV control in Africa: Clinical Efficacy, population effectiveness, political issues. In G. C. Denniston, F. M. Hodges, & M. F. Milos (Eds.), Genital autonomy protecting personal choice (pp. 49–60). Dordrecth: Springer Science & Business Media.
   Google Scholar
• Garenne, M., Giami, A., & Perrey, C. (2013). Male circumcision and HIV control in Africa: Questioning scientific evidence and the decision-making process. In T. Giles-Vernick, J. L. Webb Jr (Eds.), Global health in Africa: Historical perspectives on disease control (pp. 185–210). Athens, OH: University Press.
   Google Scholar
• Gill, C. J., Hamer, D. H., Simon, J. L., Thea, D. M., & Sabin, L. L. (2005). No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. Aids (london, England), 19(12), 1243–1249. doi: 10.1097/01.aids.0000180094.04652.3b
   PubMed Web of Science ®Google Scholar
• Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587-2599. doi: 10.1056/NEJMoa1011205
   PubMed Web of Science ®Google Scholar
• Gray, R. H., Kigozi, G., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., … Wawer, M. J. (2007). Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. The Lancet, 369(9562), 657–666. doi: 10.1016/S0140-6736(07)60313-4
   PubMed Web of Science ®Google Scholar
• Grulich, A. E., Guy, R., Amin, J., Jin, F., Selvey, C., Holden, J., … Parkhill, N. (2018). Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: The EPIC-NSW prospective cohort study. The Lancet HIV, 5(11), e629–e637. doi: 10.1016/s2352-3018(18)30215-7
   PubMed Web of Science ®Google Scholar
• Highleyman, L. (2018). PrEP use growing in US, but not reaching all those in need. NAM AIDSMAP.
   Google Scholar
• Holt, M. (2015). Configuring the users of new HIV-prevention technologies: The case of HIV pre-exposure prophylaxis. Culture, Health & Sexuality, 17(4), 428–439. doi: 10.1080/13691058.2014.960003
   PubMed Web of Science ®Google Scholar
• Holt, M., Lea, T., Mao, L., Kolstee, J., Zablotska, I., Duck, T., … Prestage, G. (2018). Community-level changes in condom use and uptake of HIV pre-exposure prophylaxis by gay and bisexual men in Melbourne and Sydney, Australia: Results of repeated behavioural surveillance in 2013–17. The Lancet HIV. doi: 10.1016/S2352-3018(18)30072-9
   Web of Science ®Google Scholar
• Horton, S., & Barker, J. C. (2009). ‘Stains’ on their self-discipline: Public health, hygiene, and the disciplining of undocumented immigrant parents in the nation’s internal borderlands. American Ethnologist, 36(4), 784–798. doi: 10.1111/j.1548-1425.2009.01210.x
   PubMed Web of Science ®Google Scholar
• International Partnership for Microbicides. (2016). Two large studies show IPM’s monthly vaginal ring helps protect women against HIV.
   Google Scholar
• Jacobs, D. L. (2018). Reported PrEP ‘failure’ most likely a lack of proper testing and adherence. TheBodyPRO. Retrieved from http://www.thebodypro.com/content/80895/reported-prep-failure-most-likely-a-lack-of-proper.html
   Google Scholar
• Kenworthy, N., & Bulled, N. (2013). From modeling to morals: Imagining the future of HIV PrEP in Lesotho. Developing World Bioethics, 13(2), 70–78. doi: 10.1111/dewb.12029
   PubMed Web of Science ®Google Scholar
• Lancet HIV. (2017). U=U taking off in 2017. The Lancet HIV, 4(11), e475. doi: 10.1016/S2352-3018(17)30183-2
   PubMed Web of Science ®Google Scholar
• Lopez, L. M., Grimes, D. A., Gallo, M. F., Stockton, L. L., & Schulz, K. F. (2013). Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database of Systematic Reviews. doi: 10.1002/14651858.CD003552.pub4
   Web of Science ®Google Scholar
• Lupton, D. (1995). The imperative of health: Public health and the regulated body. London: Sage.
   Google Scholar
• McDonnell, T. E. (2016). Best laid plans: Cultural entropy and the unravelling of AIDS media campaigns. Chicago: The University of Chicago Press.
   Google Scholar
• Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., … Bangsberg, D. R. (2006). Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. Journal of the American Medical Association, 296(6), 679–690. doi: 10.1001/jama.296.6.679
   PubMed Web of Science ®Google Scholar
• Ministry of Health and Social Welfare. (2006). WORKING DRAFT – Lesotho National ART Guidelines, Maseru, Lesotho.
   Google Scholar
• Morrow Guthrie, K., Vargas, S., Shaw, J. G., Rosen, R. K., van den Berg, J. J., Kiser, P. F., … Le Grand, R. (2015). The promise of intravaginal rings for prevention: User perceptions of biomechanical properties and implications for prevention product development. PLoS One, 10(12), e0145642. doi: 10.1371/journal.pone.0145642
   PubMed Web of Science ®Google Scholar
• Moss, J. A., Malone, A. M., Smith, T. J., Kennedy, S., Kopin, E., Nguyen, C., … Baum, M. M. (2012). Simultaneous delivery of tenofovir and Acyclovir via an intravaginal ring. Antimicrobial Agents and Chemotherapy, 56(2), 875–882. doi: 10.1128/aac.05662-11
   PubMed Web of Science ®Google Scholar
• Nel, A., van Niekerk, N., Kapiga, S., Bekker, L.-G., Gama, C., Gill, K., … Rosenberg, Z. (2016). Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. New England Journal of Medicine, 375(22), 2133–2143. doi: 10.1056/NEJMoa1602046
   PubMed Web of Science ®Google Scholar
• Nel, A., Van Niekerk, N., Van Baelen, B., & Rosenberg, Z. (2018). HIV incidence and adherence in DREAM: An open-label trial of dapivirine vaginal ring. Paper presented at the Convention for Retrovirus and Opportunistic Infections, Boston, MA.
   Google Scholar
• Nguyen, V. K., Greenwald, Z. R., Trottier, H., Cadieux, M., Goyette, A., Beauchemin, M., … Thomas, R. (2018). Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV. Aids (london, England), 32(4), 523–530. doi: 10.1097/qad.0000000000001718
   PubMed Web of Science ®Google Scholar
• Pilgrim, N., Jani, N., Mathur, S., Kahabuka, C., Saria, V., Makyao, N., … Carael, M. (2018). Provider perspectives on PrEP for adolescent girls and young women in Tanzania: The role of provider biases and quality of care. PLoS One, 13(4), e0196280. doi: 10.1371/journal.pone.0196280
   PubMed Web of Science ®Google Scholar
• Porter, D. (2005). Health, civilization, and the state. New York: Routledge.
   Google Scholar
• Rose, N. (1993). Government, authority, and expertise in advanced liberalism. Economy and Society, 22(3), 283–299. doi: 10.1080/03085149300000019
   Web of Science ®Google Scholar
• Rose, N. (1999). Powers of freedom: Reframing political thought. Cambridge: Cambridge University Press.
   Google Scholar
• Rose, N. (2007). The politics of life itself: Biomedicine, power, and subjectivity in the twenty-first century. Princeton: Princeton University Press.
   Google Scholar
• Ross, I., Mejia, C., Melendez, J., Chan, P. A., Nunn, A. C., Powderly, W., … Newman, P. A. (2017). Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementation. PLoS One, 12(3), e0173057. doi: 10.1371/journal.pone.0173057
   PubMed Web of Science ®Google Scholar
• Ryan, B. (2017). An Estimated 136,000 People Are on PrEP in the US. Poz. Retrieved from https://www.poz.com/article/estimated-136000-people-prep-us.
   Google Scholar
• Ryan, K. E., Mak, A., Stoove, M., Price, B., Fairley, C. K., Ruth, S., … Wright, E. J. (2018). Protocol for an HIV pre-exposure prophylaxis (PrEP) population level intervention study in Victoria Australia: The PrEPX study. Frontiers in Public Health, 6, 151. doi: 10.3389/fpubh.2018.00151
   PubMed Web of Science ®Google Scholar
• Shi, C. F., Li, M., & Dushoff, J. (2017). Evidence that promotion of male circumcision did not lead to sexual risk compensation in prioritized Sub-Saharan countries. PLoS One, 12(4), doi: 10.1371/journal.pone.0175928
   Web of Science ®Google Scholar
• Stewart, H. (2018). Ground breaking PrEP activist to star in BBC documentary. PinkNews. Retrieved from https://www.pinknews.co.uk/2018/06/25/prep-hiv-aids-bbc-activist-documentary/
   Google Scholar
• Thurman, A. R., Clark, M. R., Hurlburt, J. A., & Doncel, G. F. (2013). Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies. International Journal of Women's Health, 5, 695–708. doi: 10.2147/IJWH.S34030
   PubMedGoogle Scholar
• UNAIDS. (2014). Declining investment could slow research and rollout of new HIV prevention options. Geneva: UNAIDS. Retrieved from http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2014/july/20140718prvaccines
   Google Scholar
• UNAIDS. (2015). Oral pre-exposure prophylaxis: Putting a new choice in context. Geneva: UNAIDS. Retrieved from http://www.unaids.org/sites/default/files/media_asset/UNAIDS_JC2764_en.pdf
   Google Scholar
• UNAIDS. (2016). Prevention gap report. Geneva: UNAIDS. Retrieved from http://www.unaids.org/sites/default/files/media_asset/2016-prevention-gap-report_en.pdf
   Google Scholar
• UNAIDS. (2018a). 90-90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS. Retrieved from http://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf
   Google Scholar
• UNAIDS. (2018b). Press statement: UNAIDS welcomes preliminary trial results that could offer a woman a new HIV prevention option. Geneva: UNAIDS. Retrieved from http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2018/march/20180307_dapivirine_ring
   Google Scholar
• UNAIDS. (2018c). Global HIV prevention targets at risk. Geneva: UNAIDS. Retrieved from http://www.unaids.org/en/resources/presscentre/featurestories/2018/october/resource-tracking-for-hiv-prevention-r-d
   Google Scholar
• World Health Organization (WHO). (2007). New data on male circumcision and HIV prevention: Policy and programme implications. Geneva: WHO. Retrieved from http://www.who.int/hiv/pub/malecircumcision/research_implications/en/index.html
   Google Scholar
• World Health Organization (WHO). (n.d.). Microbicides. Geneva: WHO. Retrieved from http://www.who.int/hiv/topics/microbicides/microbicides/en/
   Google Scholar
• World Health Organization (WHO) Regional Office for Europe. (1978). Alma-ata declaration. Copenhagen: WHO. Retrieved from http://www.euro.who.int/en/publications/policy-documents/declaration-of-alma-ata,-1978
   Google Scholar
• Zablotska, I. B., Selvey, C., Guy, R., Price, K., Holden, J., Schmidt, H. M., … Epic-Nsw Study Group. (2018). Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): Design of an open label, single arm implementation trial. BMC Public Health, 18(1), 210. doi: 10.1186/s12889-017-5018-9
   PubMedGoogle Scholar